U.S. Markets closed

Amgen wins U.S. patent battle on arthritis drug Enbrel

A U.S. Judge up-held 2 patents relating to Amgen’s Rheumatoid Arthritis drug Enbrel after they were challenged by competitor Novartis. Yahoo Finance's Scott Gamm joins Akiko Fujita to discuss.